Works matching IS 03125963 AND DT 2022 AND VI 61 AND IP 11

Results: 11

Meropenem Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children Receiving Continuous Renal Replacement Therapy.
Published in:
Clinical Pharmacokinetics, 2022, v. 61, n. 11, p. 1609, doi. 10.1007/s40262-022-01179-2
By:
- Thy, Michael;
- Urien, Saik;
- Bouazza, Naim;
- Foissac, Frantz;
- Gana, Inès;
- Bille, Emmanuelle;
- Béranger, Agathe;
- Toubiana, Julie;
- Berthaud, Romain;
- Lesage, Fabrice;
- Renolleau, Sylvain;
- Tréluyer, Jean-Marc;
- Benaboud, Sihem;
- Oualha, Mehdi
Publication type:
Article
Correction to: Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling.
Published in:
Clinical Pharmacokinetics, 2022, v. 61, n. 11, p. 1641, doi. 10.1007/s40262-022-01178-3
By:
- Montanha, Maiara Camotti;
- Fabrega, Francesc;
- Howarth, Alice;
- Cottura, Nicolas;
- Kinvig, Hannah;
- Bunglawala, Fazila;
- Lloyd, Andrew;
- Denti, Paolo;
- Waitt, Catriona;
- Siccardi, Marco
Publication type:
Article
Pharmacokinetic Study of Conjugated Equine Estrogens in Healthy Chinese Postmenopausal Women Using a Parallel Two-Column LC–MS/MS Method.
Published in:
Clinical Pharmacokinetics, 2022, v. 61, n. 11, p. 1571, doi. 10.1007/s40262-022-01177-4
By:
- Shi, Meiyun;
- Yin, Lei;
- Sun, Yantong;
- Wang, Can;
- Cai, Lanlan;
- Zhang, Tinglan;
- Zhou, Xiaotong;
- Fawcett, J. Paul;
- Gao, Xiaoli;
- Gu, Jingkai
Publication type:
Article
Quantification of the Time Course of CYP3A Inhibition, Activation, and Induction Using a Population Pharmacokinetic Model of Microdosed Midazolam Continuous Infusion.
Published in:
Clinical Pharmacokinetics, 2022, v. 61, n. 11, p. 1595, doi. 10.1007/s40262-022-01175-6
By:
- Nassar, Yomna M.;
- Hohmann, Nicolas;
- Michelet, Robin;
- Gottwalt, Katharina;
- Meid, Andreas D.;
- Burhenne, Jürgen;
- Huisinga, Wilhelm;
- Haefeli, Walter E.;
- Mikus, Gerd;
- Kloft, Charlotte
Publication type:
Article
Optimising the Nadroparin Dose for Thromboprophylaxis During Hemodialysis by Developing a Population Pharmacodynamic Model Using Anti-Xa Levels.
Published in:
Clinical Pharmacokinetics, 2022, v. 61, n. 11, p. 1559, doi. 10.1007/s40262-022-01162-x
By:
- Jaspers, Tessa C. C.;
- Meijer, Charlotte E.;
- Vleming, Louis Jean;
- Franssen, Casper F. M.;
- Diepstraten, Jeroen;
- Lukens, Michael V.;
- van den Bemt, Patricia M. L. A.;
- Maat, Barbara;
- Khorsand, Nakisa;
- Touw, Daniël J.;
- Koomen, Jeroen V.
Publication type:
Article
The Cytokine Release Syndrome and/or the Proinflammatory Cytokines as Underlying Mechanisms of Downregulation of Drug Metabolism and Drug Transport: A Systematic Review of the Clinical Pharmacokinetics of Victim Drugs of this Drug–Disease Interaction Under Different Clinical Conditions
Published in:
Clinical Pharmacokinetics, 2022, v. 61, n. 11, p. 1519, doi. 10.1007/s40262-022-01173-8
By:
- Gatti, Milo;
- Pea, Federico
Publication type:
Article
Evaluation of Absorption and Metabolism-Based DDI Potential of Pexidartinib in Healthy Subjects.
Published in:
Clinical Pharmacokinetics, 2022, v. 61, n. 11, p. 1623, doi. 10.1007/s40262-022-01172-9
By:
- Zahir, Hamim;
- Greenberg, Jonathan;
- Shuster, Dale;
- Hsu, Ching;
- Watanabe, Kengo;
- LaCreta, Frank
Publication type:
Article
Semi-mechanistic Modeling of Hypoxanthine, Xanthine, and Uric Acid Metabolism in Asphyxiated Neonates.
Published in:
Clinical Pharmacokinetics, 2022, v. 61, n. 11, p. 1545, doi. 10.1007/s40262-022-01164-9
By:
- Chu, Wan-Yu;
- Allegaert, Karel;
- Dorlo, Thomas P. C.;
- Huitema, Alwin D. R.;
- the ALBINO Study Group;
- Franz, Axel R.;
- Rüdiger, Mario;
- Nijstad, Laura;
- Annink, Kim;
- Maiwald, Christian;
- Schroth, Michael;
- Hagen, Anja;
- Bakkali, Loubna el;
- van Weisenbruch, Mirjam M.;
- Poets, Christian F.;
- Benders, Manon;
- van Bel, Frank;
- Naulaers, Gunnar;
- Bassler, Dirk;
- Klebermass-Schrehof, Katrin
Publication type:
Article
Characterizing Absorption Properties of Dispersible Pretomanid Tablets Using Population Pharmacokinetic Modelling.
Published in:
Clinical Pharmacokinetics, 2022, v. 61, n. 11, p. 1585, doi. 10.1007/s40262-022-01163-w
By:
- Zou, Yuanxi;
- Nedelman, Jerry;
- Lombardi, Antonio;
- Pappas, Frances;
- Karlsson, Mats O.;
- Svensson, Elin M.
Publication type:
Article
Role of Genetic Polymorphisms in Drug-Metabolizing Enzyme-Mediated Toxicity and Pharmacokinetic Resistance to Anti-Cancer Agents: A Review on the Pharmacogenomics Aspect.
Published in:
Clinical Pharmacokinetics, 2022, v. 61, n. 11, p. 1495, doi. 10.1007/s40262-022-01174-7
By:
- Narendra, Gera;
- Choudhary, Shalki;
- Raju, Baddipadige;
- Verma, Himanshu;
- Silakari, Om
Publication type:
Article
Clinical Pharmacokinetics and Pharmacodynamics of Rucaparib.
Published in:
Clinical Pharmacokinetics, 2022, v. 61, n. 11, p. 1477, doi. 10.1007/s40262-022-01157-8
By:
- Liao, Mingxiang;
- Beltman, Jeri;
- Giordano, Heidi;
- Harding, Thomas C.;
- Maloney, Lara;
- Simmons, Andrew D.;
- Xiao, Jim J.
Publication type:
Article